Fibrinil MF 500 mg/250 mg Tablet is a combination medication containing Tranexamic Acid 500 mg and Mefenamic Acid 250 mg, primarily used to manage excessive bleeding and pain associated with menstrual disorders. Tranexamic Acid is an antifibrinolytic agent that works by inhibiting the breakdown of fibrin clots, thereby reducing bleeding. Mefenamic Acid is a nonsteroidal anti-inflammatory drug (NSAID) that provides effective relief from pain and inflammation by blocking the production of prostaglandins, which are responsible for pain and swelling. This combination is particularly beneficial for women experiencing heavy menstrual bleeding (menorrhagia) accompanied by dysmenorrhea (painful menstruation). Fibrinil MF helps to control bleeding while simultaneously alleviating pain, improving overall comfort during menstruation. It is typically prescribed for short-term use under medical supervision. Patients should follow the prescribed dosage and consult their healthcare provider if they have a history of bleeding disorders, kidney or liver impairment, or allergies to NSAIDs. Common side effects may include gastrointestinal discomfort, nausea, or dizziness. Avoid use during pregnancy and breastfeeding unless directed by a physician. Fibrinil MF 500 mg/250 mg Tablet offers a dual-action approach to effectively manage menstrual bleeding and pain.